Form 8.3 - Horizon Therapeutics plc

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Horizon Therapeutics plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BQPVQZ61

Date of dealing

9th May 2023

2. INTERESTS AND SHORT POSITIONS

a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,788,376

(2.093%)

59

(0.000%)

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

287,600

(0.126%)

1,252,100

(0.547%)

Total

5,075,976

(2.219%)

1,252,159

(0.547%)

b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

a) Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD) (Note 5)

Purchase

167

110.76

Purchase

800

110.79

Purchase

401

110.78

Purchase

274

110.77

Purchase

1,100

110.80

Purchase

604

110.67

Purchase

216

111.04

Purchase

1,000

110.65

Purchase

281

110.70

Sale

131

110.70

Purchase

4,104

110.86

Purchase

933

110.81

Purchase

800

110.51

Purchase

813

110.58

Purchase

436

110.66

Purchase

2

110.74

Purchase

123

110.69

Purchase

1,377

110.57

Purchase

36

110.75

Purchase

2,007

110.52

Purchase

150

110.64

Purchase

775

110.50

Purchase

100

110.49

Purchase

612

110.56

Purchase

808

110.60

Purchase

9,523

111.00

Purchase

2,301

110.99

Purchase

100

110.97

Purchase

1,510

110.88

Purchase

800

110.63

Purchase

103

110.59

Purchase

500

110.98

Purchase

900

110.85

Purchase

34

111.02

Purchase

1,200

110.91

Purchase

300

110.82

Purchase

848

110.89

Purchase

5,837

110.87

Purchase

1,141

110.95

Purchase

300

110.94

Purchase

3,925

110.90

Purchase

1,728

110.83

Purchase

700

110.92

Purchase

789

110.84

Purchase

475

110.96

Purchase

12

110.55

Purchase

1

111.04

Purchase

24

110.65

Purchase

35

110.57

Purchase

24

110.72

Purchase

12

110.75

Sale

2

110.88

Purchase

166

110.98

Purchase

12

111.01

Sale

72

111.01

Purchase

6

110.85

Purchase

31

111.02

Sale

15

111.02

Purchase

11

111.03

Sale

15

111.03

Sale

31

110.91

Sale

26

110.89

Purchase

87

110.87

Sale

18

110.90

Purchase

12

110.47

Purchase

6

110.84

Purchase

1

110.96

Purchase

18

111.13

Sale

500

110.76

Sale

2,296

110.79

Sale

500

110.78

Sale

756

110.77

Sale

209

110.80

Sale

9

110.67

Sale

1,888

111.04

Purchase

1,838

110.65

Sale

650

110.65

Sale

591

110.70

Sale

409

110.86

Sale

400

110.81

Purchase

100

110.51

Sale

6

110.51

Purchase

2,500

110.69

Sale

3,400

110.69

Purchase

1,302

110.57

Sale

35

110.57

Sale

199

110.72

Sale

5,000

110.75

Purchase

5,825

110.52

Sale

45

110.52

Sale

2,845

110.64

Purchase

560

110.50

Sale

2,000

110.71

Sale

47

110.56

Sale

10

110.60

Sale

9,342

111.00

Sale

28

110.97

Purchase

543

110.88

Sale

530

110.88

Sale

1,300

110.63

Sale

4,617

110.98

Sale

1,031

111.01

Purchase

6

110.62

Sale

5,300

110.62

Purchase

100

110.85

Sale

1,294

110.85

Purchase

1,800

111.02

Sale

3,754

111.02

Sale

1,100

111.03

Sale

278

110.91

Sale

1,000

111.10

Sale

2,624

111.17

Sale

1,175

111.18

Sale

1,200

111.23

Sale

2,230

110.73

Sale

25

110.82

Purchase

286

110.89

Purchase

1,473

110.87

Sale

247

110.87

Sale

40

110.94

Sale

10,011

110.90

Sale

220

110.83

Purchase

151

110.84

Sale

332

110.96

Sale

300

111.14

Sale

80

111.15

Sale

200

111.08

Purchase

4,000

110.53

Sale

1,000

111.25

Sale

200

111.20

Sale

105

110.61

Sale

199

110.55

Sale

59

111.04

b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

 

 

 

 

c) Options transactions in respect of existing relevant securities

i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Put Option

Selling

31,500

100.00

American

5/19/2023

 

ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

10th May 2023

Contact name

Sirina Kumar

Telephone number

+44 203 192 8741

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making
disclosure:

Millennium International Management LP

Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates:

Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of
relevant
security

Product
description
e.g. call
option

Written or
purchased

Number of
securities to
which option
or derivative
relates

Exercise
price
per unit

(USD)

Type
e.g.
American,
European
etc.

Expiry
date

IE00BQPVQZ61

Put Option

Purchased

1,100

90.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

11,500

110.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Written

262,400

115.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

42,500

120.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

35,400

110.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

2,900

80.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

300

80.00

American

1/17/2025

IE00BQPVQZ61

Put Option

Purchased

300

90.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Purchased

1,200

110.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

201,200

115.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

221,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

223,500

100.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

3,600

105.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

10,900

105.00

American

7/21/2023

IE00BQPVQZ61

Call Option

Written

100,000

115.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

46,600

85.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

155,000

100.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Purchased

300

110.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

300

110.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

200,000

100.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

3,500

95.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Written

300

110.00

American

7/21/2023

IE00BQPVQZ61

Put Option

Written

300

110.00

American

7/21/2023

IE00BQPVQZ61

Call Option

Written

400

100.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

101.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

102.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

103.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

104.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

105.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

106.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

107.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

108.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

109.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

110.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

111.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

600

100.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

800

101.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

700

102.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

700

103.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

104.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

105.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

106.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

107.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

108.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

109.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

110.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

111.00

American

5/12/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET
Sequence Number: 1094027
Time of Receipt (offset from UTC): 20230510T134611+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.